Check this out: Multivitamins and prostate cancer … gotta run….

Flossmann and Rothwell, published in the Lancet a review of two studies: the British Doctors Aspirin Trial (N=5139, two-thirds allocated 500 mg aspirin for 5 years, one third to open control) and UK-TIA Aspirin Trial (N=2449, two-thirds allocated 300 mg or 1200 mg aspirin for 1–7 years, one third placebo-controlled).

After ten years of follow-up, there was a statistically significant reduction in colorectal cancers among those who had received aspirin. The was a 40% relative reduction in new diagnosis of colorectal cancers among those who had received aspirin for at least five years.

Other studies have shown that there was no reduction in colorectal cancers in patients who used aspirin at lower doses.

There are a number of other protective effects of aspirin, e.g. against heart attacks. However, there are undesirable effects of aspirin as well, such as gastric ulcers. So it’s a balance between the benefits and hazards of taking aspirin.

I love you, Mom. From Joseph and I.

HAPPY NURSES’ DAY!

The theme for Nurses’ Day celebrations for this year is “Positive practice environments:
Quality workplaces = quality patient care”

Nurses in various uniforms: